|
2026
|
Invention
|
Antibody-drug conjugate comprising anti-itgb6 antibody. The present invention provides an antibod... |
|
2025
|
Invention
|
Antibody-dual drug conjugate comprising asymmetric antibody and method for preparing same. The pr... |
|
|
Invention
|
Antibody-drug conjugate comprising heterogeneous drugs and method for preparing same. The present... |
|
2024
|
Invention
|
Composition for treating blood cancer using 4'-thio-5-aza-2'-deoxycytidine and uses thereof.
The... |
|
|
Invention
|
Carrier-drug conjugate comprising heterogeneous drugs and method for preparing same. The present ... |
|
|
Invention
|
Anti-tissue factor antibody-drug conjugate comprising camptothecin derivative. The present invent... |
|
|
Invention
|
Carrier-drug conjugate and combination therapy with dnmt-1 inhibitor. The present invention relat... |
|
|
Invention
|
Novel camptothecin derivative and carrier-drug conjugate comprising same. The present invention r... |
|
|
Invention
|
Novel hemiasterlin derivative and use thereof.
The present invention provides a novel hemiasterl... |
|
|
Invention
|
Novel hemiasterlin derivative and use thereof. The present invention provides a novel hemiasterli... |
|
|
Invention
|
Antibody-drug conjugate in which one or more drug-linker conjugates are linked to antibody and me... |
|
|
Invention
|
Novel camptothecin derivative to overcome anticancer resistance and antibody-drug conjugate conta... |
|
|
Invention
|
Oral formulation for precisely controlling peak plasma concentration of 5-aza-4'-thio-2'-deoxycyt... |
|
|
Invention
|
Linker for antibody-drug conjugate.
Provided herein are a linker compound, a linker-drug conjuga... |
|
|
Invention
|
Linker for antibody-drug conjugate |
|
|
Invention
|
Linker for antibody-drug conjugate. Provided herein are a linker compound, a linker-drug conjugat... |
|
2023
|
Invention
|
Novel camptothecin derivatives and carrier-drug conjugate comprising same. The present invention ... |
|
|
Invention
|
Antibody-drug conjugate having camptothecin-based drug linked to antibody having low antigen-bind... |
|
|
Invention
|
Camptothecin derivatives that bind to ddx5 protein and prodrugs thereof.
The present invention r... |
|
|
Invention
|
Camptothecin derivatives that bind to ddx5 protein and prodrugs thereof |
|
|
Invention
|
Ddx5 protein-binding camptothecin derivatives and prodrugs thereof. The present invention relates... |
|
|
Invention
|
Antibody-drug conjugate with two types of drug-linker conjugates on single antibody.
Provided is... |
|
|
Invention
|
Antibody-drug conjugate with two types of drug-linker conjugates on single antibody. The present ... |
|
|
Invention
|
Method for preparing 4'-thio-5-aza-2'-deoxycytidine.
The present invention relates to a method f... |
|
|
Invention
|
Method for preparing 4'-thio-5-aza-2'-deoxycytidine. The present invention relates to a method fo... |
|
|
Invention
|
Conjugate of ddx5 protein-binding camptothecin-based drug linked to acid-sensitive linker and imm... |
|
|
Invention
|
Pharmaceutical composition for administration as ophthalmic drop to patient requiring optic nerve... |
|
|
Invention
|
Camptothecin derivatives that bind to ddx5 protein and prodrugs thereof. The present invention re... |
|
|
Invention
|
Oral formulation containing 5-aza-4'-thio-2'-deoxycytidine and preparation method therefor. The p... |
|
2022
|
Invention
|
Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell... |
|
|
Invention
|
Medicinal use of 4'-thio-5-aza-2'-deoxycytidine selected as well-designed multi-target inhibitor.... |
|
|
Invention
|
Combined therapy of 4′-thio-5-aza-2′-deoxycytidine and venetoclax. The present invention relates ... |
|
|
Invention
|
Combined therapy of 4'-thio-5-aza-2'-deoxycytidine and venetoclax. The present invention relates ... |
|
|
Invention
|
Benzothiazole and benzimidazole derivatives, pharmaceutically acceptable salt thereof, preparatio... |
|
2021
|
Invention
|
Conjugate including deoxycytidine-based anticancer agent and silyl ether-containing linker. The p... |
|
|
Invention
|
Polymorphs of 5-aza-4'-thio-2'-deoxycytidine. The present disclosure provides crystalline polymor... |
|
|
Invention
|
Polymorophs of 5-aza-4′-thio-2′-deoxycytidine. The present disclosure provides crystalline polymo... |
|
|
Invention
|
Conjugate in which fl118 drug is linked to acid-sensitive linker, and immunoconjugate using same.... |
|
|
Invention
|
Conjugate in which fl118 drug is linked to acid-sensitive linker, and immunoconjugate using the s... |
|
|
Invention
|
Composition for treating blood cancer using 4′-thio-5-aza-2′-deoxycytidine and uses thereof. The ... |
|
|
Invention
|
Composition for treating blood cancer using 4'-thio-5-aza-2'-deoxycytidine and uses thereof. The ... |
|
2020
|
Invention
|
Dinucleotide compounds for treating cancers and medical uses thereof.
The present disclosure pro... |
|
|
Invention
|
Dinucleotide compounds for treating cancers and medical uses thereof. The present disclosure prov... |
|
|
G/S
|
Pharmaceutical research services in the field of anti-cancer preparations, pharmaceutical product... |
